USFDA APPLICATION NUMBER - 22271 / DOSAGE - TABLET;ORAL - EQ 25MG BASE
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
Alogliptin Benzoate(UNII: EEN99869SC) (Alogliptin - UNII:JHC049LO86) | Alogliptin | 25mg | 12.5mg | 6.25mg |
Inactive Ingredients
Ingredient Name | Padagis Israel Pharmaceuticals Ltd |
---|---|
Alcohol(3K9958V90M) | |
Butyl Alcohol(8PJ61P6TS3) | |
Croscarmellose sodium(M28OL1HH48) | |
Ferric oxide Red(1K09F3G675) | |
Ferric oxide Yellow(EX438O2MRT) | |
Ferrosoferric oxide(XM0M87F357) | |
HYDROXYPROPYL CELLULOSE (90000 WAMW)(UKE75GEA7F) | |
Hypromellose 2910 (6 MPA.S)(0WZ8WG20P6) | |
Magnesium stearate(70097M6I30) | |
Mannitol(3OWL53L36A) | |
Microcrystalline Cellulose(OP1R32D61U) | |
Polyethylene Glycol 8000(Q662QK8M3B) | |
Shellac(46N107B71O) | |
Titanium dioxide(15FIX9V2JP) |
LOOKING FOR A SUPPLIER?